盛夏
Lv31
360 积分
2022-12-12 加入
-
Real-World Use of Semaglutide for Weight Management: Patient Characteristics and Dose Titration—A Danish Cohort Study
1小时前
已完结
-
The efficacy and safety of iGlarLixi versus IDegAsp in Chinese people with type 2 diabetes suboptimally controlled with oral antidiabetic drugs: The Soli‐D randomized controlled trial
2个月前
已完结
-
Efficacy and safety of once-weekly semaglutide 2·4 mg versus placebo in people with obesity and prediabetes (STEP 10): a randomised, double-blind, placebo-controlled, multicentre phase 3 trial
2个月前
已完结
-
Vosoritide therapy in children with achondroplasia aged 3−59 months: a multinational, randomised, double-blind, placebo-controlled, phase 2 trial
2个月前
已完结
-
Semaglutide improves cardiovascular health independently of weight loss
2个月前
已完结
-
Oral Immunotherapy
2个月前
已完结
-
IL-1 in Aging and Pathologies of Hematopoietic Stem Cells
3个月前
已完结
-
Vosoritide therapy in children with achondroplasia aged 3−59 months: a multinational, randomised, double-blind, placebo-controlled, phase 2 trial
4个月前
已完结
-
Withdrawal studies
4个月前
已关闭
-
Efficacy and safety of once weekly semaglutide 2·4 mg for weight management in a predominantly east Asian population with overweight or obesity (STEP 7): a double-blind, multicentre, randomised controlled trial
5个月前
已完结